Skip to main navigation Skip to search Skip to main content

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.

  • Casey Mason
  • , Peter G Ellis
  • , Kathy Lokay
  • , Amanda Barry
  • , Natalie Dickson
  • , Ray Page
  • , Blase Polite
  • , Ravi Salgia
  • , Michael Savin
  • , Corey Shamah
  • , Mark A Socinski
  • Florida State University
  • UPMC Cancer Center, Pittsburgh, PA.
  • Via Oncology, Pittsburgh, PA.
  • Tennessee Oncology, Nashville, TN
  • The Center for Cancer and Blood Disorders, Fort Worth, TX.
  • University of Chicago
  • City of Hope National Medical Center
  • Oregon Health & Science University
  • Aurora Health Care
  • Florida Hospital Cancer Institute, Orlando, FL.

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of clinical pathways : the foundation of value-based care
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this